Resource Guide: Scientific evidence connecting Benzene to Acute Myeloid Leukemia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Primary topic reference

Scientific evidence connecting Benzene to Acute Myeloid Leukemia

Detailed background, context, and analysis on this topic, compiled for open research purposes.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.